PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas.
Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.
* E-mail: firstname.lastname@example.org
Universidad Peruana Cayetano Heredia, Lima, Peru,
Imperial College London Hammersmith Hospital Campus, London, United Kingdom,
IFHAD: Innovation For Health And Development, London, United Kingdom
Post a new comment on this article
Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study
Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
We want your feedback. Do these subject areas make sense for this article? If not, click the flag
next to the incorrect subject area and we will review it. Thanks for your help!
Ambra 2.10.22 Managed Colocation provided by Internet Systems Consortium.
Send us feedback
Help using this site